OUTCOMES OF 12-WEEK THERAPY WITH SIMEPREVIR plus SOFOSBUVIR plus /- RIBAVIRIN (SMV plus SOF +/- RBV): A META-ANALYSIS OF 7 STUDIES AND 715 HCV GENOTYPE 1 (HCV-1) PATIENTS Yee, B. E., Nguyen, N. H., Lutchman, G. A., Lim, J. K., Nguyen, M. H. ELSEVIER SCIENCE BV. 2015: S668–S669

View details for DOI 10.1016/S0168-8278(15)31076-X

View details for Web of Science ID 000362830900069